Top Stocks Under $10

Primed to grow right now with long-term potential gains of 2X and more.

Primed to grow right now with long-term potential gains of 2X and more.

A Guide to the 10 Most Popular Dividend ETFs

We have highlighted the 10 most popular dividend ETFs for investors seeking steady income irrespective of stock market directions.

We have highlighted the 10 most popular dividend ETFs for investors seeking steady income irrespective of stock market directions.

New Strong Buy Stocks for June 5th

This explorer and producer of oil and natural gas has seen the Zacks Consensus Estimate for its current year earnings increasing 39.5% over the last 60 days.

This explorer and producer of oil and natural gas has seen the Zacks Consensus Estimate for its current year earnings increasing 39.5% over the last 60 days.

AWS 6/5: ADP Payrolls Depict Cooling Labor Market

ADP numbers for May came down for the second month in a row to 152K from a downwardly revised 188K for March.

ADP numbers for May came down for the second month in a row to 152K from a downwardly revised 188K for March.

PFP 6/5: We're All On the NVIDIA Train

As long as the NVIDIA story is a good one, look for the big-cap indexes to continue to ride the AI wave.

As long as the NVIDIA story is a good one, look for the big-cap indexes to continue to ride the AI wave.

Brian's Big Idea on Bitcoin

With BTC surging back over $70,000 interest has returned to the space.

With BTC surging back over $70,000 interest has returned to the space.

4 Factors That Drive Share Outperformance

All investors look to reap outsized gains, precisely what these particular stocks we have chosen have provided. But what factors have been aiding the moves?

All investors look to reap outsized gains, precisely what these particular stocks we have chosen have provided. But what factors have been aiding the moves?

ETFs to Profit from the Weight Loss Drug Boom

According to Goldman Sachs, the market for these drugs could surge to $130 billion by 2030, with Eli Lilly and Novo Nordisk retaining about 80% of the market share.

According to Goldman Sachs, the market for these drugs could surge to $130 billion by 2030, with Eli Lilly and Novo Nordisk retaining about 80% of the market share.

Top Analyst Reports for Roche, Wells Fargo & GE Aerospace

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Wells Fargo & Co. (WFC) and GE Aerospace (GE), as well as a micro-cap stock Key Tronic Corp. (KTCC).

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Wells Fargo & Co. (WFC) and GE Aerospace (GE), as well as a micro-cap stock Key Tronic Corp. (KTCC).